|
|
|
Volumn 16, Issue 88, 2007, Pages 56-58
|
|
Nitisinone. Type 1 tyrosinemia: An effective drug
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOCHROME P450 3A4;
NITISINONE;
PHENOBARBITAL;
PHENYLALANINE;
TYROSINE;
CYCLOHEXANONE DERIVATIVE;
ENZYME INHIBITOR;
NITROBENZOIC ACID DERIVATIVE;
ANEMIA;
ARTICLE;
BLEPHARITIS;
BONE MALFORMATION;
CHILDHOOD MORTALITY;
CLINICAL TRIAL;
CONJUNCTIVITIS;
CORNEA OPACITY;
DIET RESTRICTION;
DISEASE ASSOCIATION;
DRUG BLOOD LEVEL;
DRUG CONTRAINDICATION;
DRUG DOSE INCREASE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG MONITORING;
DRUG POTENTIATION;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG WITHDRAWAL;
EARLY INTERVENTION;
ENZYME DEFICIENCY;
ERYTHEMA;
EVIDENCE BASED MEDICINE;
EXFOLIATIVE DERMATITIS;
EYE DISEASE;
EYE PAIN;
HEREDITARY TYROSINEMIA TYPE 1;
HUMAN;
KERATITIS;
LEUKOPENIA;
LIVER CANCER;
LIVER DISEASE;
LIVER FAILURE;
LIVER TRANSPLANTATION;
LOW DRUG DOSE;
NEUROLOGIC DISEASE;
NONHUMAN;
ONSET AGE;
OUTCOME ASSESSMENT;
PHOTOPHOBIA;
PREGNANCY;
PRURITUS;
QUALITY OF LIFE;
RISK BENEFIT ANALYSIS;
SEIZURE;
SKIN DISEASE;
SKIN EXFOLIATION;
SURVIVAL RATE;
THROMBOCYTOPENIA;
TYROSINEMIA;
UNSPECIFIED SIDE EFFECT;
VISUAL DISORDER;
CHILD;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
DRUG APPROVAL;
EUROPE;
INFANT;
MORTALITY;
NEWBORN;
PRESCHOOL CHILD;
TIME;
CHILD;
CHILD, PRESCHOOL;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
CYCLOHEXANONES;
DRUG APPROVAL;
ENZYME INHIBITORS;
EUROPE;
HUMANS;
INFANT;
INFANT, NEWBORN;
NITROBENZOATES;
SURVIVAL RATE;
TIME FACTORS;
TYROSINEMIAS;
|
|
EID: 34248378313
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (7)
|
|
References (5)
|
